Hermonville, France

Jean-Jacques M Lohmann

This inventor holds 1 USPTO granted patent. Top assignee: Ici Pharma. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Jacques M Lohmann. Retrieved from https://idiyas.com/inventor/jean-jacques-m-lohmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Jacques M Lohmann

Introduction

Jean-Jacques M Lohmann is a notable inventor based in Hermonville, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin derivatives. His work has led to advancements in antibiotic compounds that are crucial for medical applications.

Latest Patents

Jean-Jacques M Lohmann holds one patent related to cephalosporin compounds. This patent describes cephalosporin compounds having a 3-position substituent of a specific formula. His innovative approach in this area has the potential to enhance the effectiveness of antibiotic treatments.

Career Highlights

Lohmann is associated with Ici Pharma, a company known for its focus on pharmaceutical research and development. His work at Ici Pharma has allowed him to explore and develop new medicinal compounds that can address various health challenges.

Collaborations

Throughout his career, Jean-Jacques M Lohmann has collaborated with notable colleagues, including Alain M Bertrandie and Thomas G Bird. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical sciences.

Conclusion

Jean-Jacques M Lohmann's contributions to the field of pharmaceuticals, particularly through his patent on cephalosporin derivatives, highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…